KR0183446B1 - 에이치아이브이-억제성 벤젠아세트아미드 유도체 - Google Patents

에이치아이브이-억제성 벤젠아세트아미드 유도체 Download PDF

Info

Publication number
KR0183446B1
KR0183446B1 KR1019930700032A KR930700032A KR0183446B1 KR 0183446 B1 KR0183446 B1 KR 0183446B1 KR 1019930700032 A KR1019930700032 A KR 1019930700032A KR 930700032 A KR930700032 A KR 930700032A KR 0183446 B1 KR0183446 B1 KR 0183446B1
Authority
KR
South Korea
Prior art keywords
hydrogen
alkyl
parts
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930700032A
Other languages
English (en)
Korean (ko)
Inventor
헨리 파울 반 댈레 게오르게스
구스타프 셀리네 베르돈크 마르크
레네 마리에 안드레 보스만스 예안-파울
안드리안 얀 얀센 파울
조성환
Original Assignee
디르크 반테
얀센 파마슈티카 엔.브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디르크 반테, 얀센 파마슈티카 엔.브이 filed Critical 디르크 반테
Application granted granted Critical
Publication of KR0183446B1 publication Critical patent/KR0183446B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019930700032A 1990-07-10 1991-07-04 에이치아이브이-억제성 벤젠아세트아미드 유도체 Expired - Fee Related KR0183446B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP90201857 1990-07-10
EP90201857.1 1990-07-10
BE91200646.7 1991-03-22
EP91200646 1991-03-22
PCT/EP1991/001254 WO1992000952A1 (en) 1990-07-10 1991-07-04 Hiv-inhibiting benzeneacetamide derivatives

Publications (1)

Publication Number Publication Date
KR0183446B1 true KR0183446B1 (ko) 1999-05-15

Family

ID=26125946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700032A Expired - Fee Related KR0183446B1 (ko) 1990-07-10 1991-07-04 에이치아이브이-억제성 벤젠아세트아미드 유도체

Country Status (42)

Country Link
US (2) US5556886A (enExample)
EP (1) EP0538301B1 (enExample)
JP (1) JPH0819068B2 (enExample)
KR (1) KR0183446B1 (enExample)
CN (2) CN1028990C (enExample)
AP (1) AP311A (enExample)
AT (1) ATE144765T1 (enExample)
AU (1) AU643056B2 (enExample)
BG (1) BG61809B1 (enExample)
CA (1) CA2084508A1 (enExample)
CZ (1) CZ279901B6 (enExample)
DE (1) DE69122963T2 (enExample)
DK (1) DK0538301T3 (enExample)
DZ (1) DZ1514A1 (enExample)
ES (1) ES2095942T3 (enExample)
FI (1) FI930070A0 (enExample)
GR (1) GR3021829T3 (enExample)
HR (1) HRP930485A2 (enExample)
HU (2) HUT64013A (enExample)
IE (1) IE75693B1 (enExample)
IL (3) IL111924A (enExample)
LT (1) LT3602B (enExample)
LV (1) LV10086B (enExample)
MA (1) MA22208A1 (enExample)
MX (1) MX9100100A (enExample)
MY (1) MY108580A (enExample)
NO (1) NO303777B1 (enExample)
NZ (1) NZ238763A (enExample)
OA (1) OA09770A (enExample)
PH (1) PH30977A (enExample)
PL (1) PL167076B1 (enExample)
PT (1) PT98259B (enExample)
RO (1) RO112855B1 (enExample)
RU (1) RU2087465C1 (enExample)
SG (1) SG48829A1 (enExample)
SI (1) SI9111204A (enExample)
SK (1) SK279639B6 (enExample)
TN (1) TNSN91056A1 (enExample)
TW (1) TW204337B (enExample)
WO (1) WO1992000952A1 (enExample)
YU (1) YU120491A (enExample)
ZA (1) ZA915334B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE149484T1 (de) * 1991-12-30 1997-03-15 Janssen Pharmaceutica Nv Alpha-substituierte benzenmethanamin-derivate
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
ATE141254T1 (de) * 1992-07-06 1996-08-15 American Cyanamid Co O-nitrophenyl cyclopropyl keton, herbizides zwischenprodukt und verfahren zu seiner herstellung
EP0684818B1 (en) * 1993-02-22 1999-05-06 Janssen Pharmaceutica N.V. Method of reversing resistance of hiv-1 strains to zidovudine
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
GB9403449D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
GB9403408D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
IL112739A0 (en) * 1994-02-23 1995-05-26 Wellcome Found Ayrlthiobenzonitrile compounds, their preparation and pharmaceutical compositions containing them
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
KR100554815B1 (ko) * 1997-08-22 2006-02-22 에프. 호프만-라 로슈 아게 엔-아로일페닐알라닌 유도체
WO1999065871A2 (en) * 1998-06-19 1999-12-23 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Thiolesters and uses thereof
TR200200763T2 (tr) 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
US6916956B2 (en) 2000-08-11 2005-07-12 Japan Tobacco, Inc. Calcium receptor antagonist
AU2005235692B2 (en) * 2004-04-23 2011-11-10 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
EP2061756B1 (en) * 2006-06-08 2013-09-25 Bristol-Myers Squibb Company 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants
RU2449985C2 (ru) * 2010-03-31 2012-05-10 Федеральное государственное унитарное предприятие "Российский научный центр "Прикладная химия" Способ получения n,n-диметилацетамида
CN102675212B (zh) * 2012-05-09 2014-11-05 昆明理工大学 N-取代苯基-2-((1h-苯并咪唑-2-基)巯基)乙酰胺类衍生物及其用途
CN104000807B (zh) * 2014-05-28 2016-05-18 中山大学 苯基-酰胺类化合物在制备抗hiv-1病毒药物中的应用
CN105367437B (zh) * 2015-10-12 2017-08-01 湖北文理学院 一种2‑芳氨基乙酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1423430A (en) * 1973-03-29 1976-02-04 Wyeth John & Brother Ltd Thioamides
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
CH637828A5 (en) * 1978-11-15 1983-08-31 Koehler Franz Dr Chemie Kg Cytostatics
ATE149484T1 (de) * 1991-12-30 1997-03-15 Janssen Pharmaceutica Nv Alpha-substituierte benzenmethanamin-derivate

Also Published As

Publication number Publication date
LT3602B (en) 1995-12-27
DK0538301T3 (da) 1996-11-25
MX9100100A (es) 1992-02-28
EP0538301B1 (en) 1996-10-30
US5684049A (en) 1997-11-04
IE75693B1 (en) 1997-09-10
PH30977A (en) 1997-12-23
TW204337B (enExample) 1993-04-21
SI9111204A (en) 1995-04-30
BG97265A (bg) 1994-03-24
JPH0819068B2 (ja) 1996-02-28
PL297608A1 (enExample) 1992-07-13
CN1107835A (zh) 1995-09-06
IL98756A (en) 1996-06-18
WO1992000952A1 (en) 1992-01-23
ATE144765T1 (de) 1996-11-15
AU643056B2 (en) 1993-11-04
ZA915334B (en) 1993-03-31
FI930070A7 (fi) 1993-01-08
LV10086B (en) 1995-02-20
NO930047D0 (no) 1993-01-07
IE912208A1 (en) 1992-01-15
JPH05507931A (ja) 1993-11-11
US5556886A (en) 1996-09-17
PL167076B1 (pl) 1995-07-31
MY108580A (en) 1996-10-31
CN1033142C (zh) 1996-10-30
PT98259A (pt) 1992-04-30
NZ238763A (en) 1993-10-26
LTIP848A (en) 1995-02-27
NO930047L (no) 1993-01-07
RU2087465C1 (ru) 1997-08-20
HU211873A9 (en) 1995-12-28
AU8212091A (en) 1992-02-04
LV10086A (lv) 1994-05-10
AP311A (en) 1994-02-01
CN1058958A (zh) 1992-02-26
HUT64013A (en) 1993-11-29
IL111924A0 (en) 1995-03-15
SK210291A3 (en) 1995-07-11
ES2095942T3 (es) 1997-03-01
CS210291A3 (en) 1992-02-19
HRP930485A2 (en) 1996-06-30
DE69122963T2 (de) 1997-03-13
FI930070A0 (fi) 1993-01-08
PT98259B (pt) 1998-12-31
DE69122963D1 (de) 1996-12-05
HU9300032D0 (en) 1993-04-28
DZ1514A1 (fr) 2004-09-13
CZ279901B6 (cs) 1995-08-16
OA09770A (fr) 1993-11-30
MA22208A1 (fr) 1992-04-01
IL111924A (en) 1996-12-05
SG48829A1 (en) 1998-05-18
CA2084508A1 (en) 1992-01-11
AP9100288A0 (en) 1991-07-31
GR3021829T3 (en) 1997-02-28
IL98756A0 (en) 1992-07-15
TNSN91056A1 (fr) 1992-10-25
CN1028990C (zh) 1995-06-21
YU120491A (sh) 1994-06-10
NO303777B1 (no) 1998-08-31
SK279639B6 (sk) 1999-01-11
BG61809B1 (bg) 1998-06-30
EP0538301A1 (en) 1993-04-28
RO112855B1 (ro) 1998-01-30

Similar Documents

Publication Publication Date Title
EP0538301B1 (en) Hiv-inhibiting benzeneacetamide derivatives
EP2058296B1 (fr) Nouvelle forme cristalline VI de l'agomélatine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent
JPH07316113A (ja) 新規アリールアルキル（チオ）アミド化合物
JPH10510513A (ja) 新規ベンゾオキサゾール類
KR20090071632A (ko) 가축 동물에 대한 동화 제제로서 유용한 헤테로사이클릭 화합물
FR2889523A1 (fr) Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889522A1 (fr) Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521A1 (fr) Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
HUT67030A (en) Alpha-substituted benzenemethanamine deriv., pharmaceutical compn. contg. said compd. and process for prepg. them
FR2649612A1 (fr) Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
JP2000511528A (ja) アルキルオキシアミノ置換フルオレノンおよびプロテインキナーゼｃ阻害剤としてのその使用
JPS62234083A (ja) 鎮吐薬または精神病治療薬として有用なカルボキサミド類
JPH0156071B2 (enExample)
FI82926C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara fenetylaminderivat.
GB1586249A (en) Aminoalkyl-bicycloheptanes
JPH0667882B2 (ja) フェニルカルボン酸誘導体
HK1195297B (en) Biarylderivatives, their preparation and their therapeutic application
HK1195297A (en) Biarylderivatives, their preparation and their therapeutic application

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20011217

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20011217

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000